Mandaviya inaugurates EPFO's first-ever Modernised Digital Pavilion at IITF 2025 (See 'Corp Brief') NHAI takes Initiative to Publish Updates for Underbidding Projects on Website (See 'Corp Brief') India, Russia hold High-Level Interagency Consultations in New Delhi (See 'Corp Brief') Gati Shakti Vishwavidyalaya, DRDO sign MoU to develop Smart Tech Solutions (See 'Corp Brief') Misc - Legal heirs who are guilty of misconduct disentitles them to seek indulgence of Court to condone delay: HC (See 'Legal Desk') India unveils ARKA-GKT1, First Generation Energy-Efficient Edge Silicon Chip (See 'Corp Brief') MSME, KVIC, COIR and NSSH Pavilions inaugurated at Trade Fair (See 'Corp Brief') India highlights Rapid Telecom Transformation; Urges Collaborative Cybersecure Future (See 'Corp Brief') 5 institutes of Ministry of Earth Sciences brought under single umbrella (See 'Corp Brief') From Markets to Monuments: Advancing Clean Toilets and Hygienic Spaces (See 'Corp Brief') Capital Market - Fact that transactions in particular contract were reversed with same counterparty for same quantity of units, indicates prior meeting of minds with view to execute reversal trades at pre-determined price: SEBI (See 'Legal Desk') Puri visits Hanwha Ocean's shipbuilding facility in South Korea (See 'Corp Brief') IPR - Mere fact that any mark consists of numbers does not, in itself, make it unregistrable: HC (See 'Legal Desk') IndiaAI Zone unveiled showcasing India's Journey from Action to Impact (See 'Corp Brief') IPR - Counterfeiting not only harms brand reputation but also misleads consumers, making strict legal action necessary to deter such unlawful practices: HC (See 'Legal Desk') Puri holds Shipbuilding Meetings to boost India's Maritime Vision (See 'Corp Brief') Company Law - Company can prosecute any of its officers and when any officer of Company is to be prosecuted, then Section 439 of Companies Act would not be applicable: HC (See 'Legal Desk') AAI showcases future of Aviation at 44th India International Trade Fair 2025 (See 'Corp Brief') IPR - Mere identity or similarity of mark, of which registration is sought, and earlier mark, is not sufficient as ground to reject registration application: HC (See 'Legal Desk') India-Canada Ministerial Dialogue on Trade and Investment concludes (See 'Corp Brief') Misc - Remedy for recovery of money instituted under Article 226 of Constitution of India is not intended to enable claimant to recover monies, recovery of which by suit is barred by limitation: HC (See 'Legal Desk') Government intervention and Corporate governance (See CORP EINSICHT)

Print

CCI okays internal acquisition by Glaxo Smith Kline

Published: Jan 24, 2022

By TIOLCorplaws News Service

NEW DELHI, JAN 24, 2022: THE Competition Commission of India (CCI) approves acquisition by GlaxoSmithKline Consumer Healthcare Overseas Limited and GlaxoSmithKline Consumer Healthcare UK Trading Limited (Acquirers) of shareholding in GlaxoSmithKline Asia Private Limited (Target) under Section 31(1) of the Competition Act, 2002.

The Proposed Combination involves collective acquisition of 100% shares of the Target by the Acquirers. Further, prior to the proposed combination, GSKAPL will acquire the trademarks pertaining to "Iodex" and "Ostocalcium" brands in India alongwith the legal, economic, commercial and marketing rights of such brands and other associated assets (GSK Consumer Brands) from GlaxoSmithKline Pharmaceuticals Limited.

GlaxoSmithKline Consumer Healthcare Overseas Limited is a wholly-owned subsidiary of GlaxoSmithKline Consumer Healthcare Holdings (No.2) Limited ("GSK CH HoldCo"). It is a part of the overall GlaxoSmithkline (GSK) group and its principal activity is to act as an investment holding company for GSK CH HoldCo and its subsidiaries.

GlaxoSmithKline Consumer Healthcare UK Trading Limited is a part of the overall GSK group and is a wholly-owned subsidiary of GSK CH HoldCo. It is engaged in the distribution and sale of consumer healthcare products, manufacturing, marketing, providing management services to the consumer healthcare group and providing research and development services to other consumer healthcare companies within the GSK group.

GSKAPL is a consumer healthcare company that is engaged in the marketing and distribution of oral healthcare products under various brand names such as Sensodyne, Parodontax, Polident and over-the-counter medicines products under the brand names such as Crocin, ENO. 

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
tioltube
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.